The GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTThe GLP Weekend25% off GLPs15% off automatically25% with any codeEnds Sunday 11:59 PM PTNEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →Same-day shipping now live from the US West Coast · order by 2:30 PM PT weekdays, 12:00 PM PT Saturday →NEW Verify Your Product · test your vial at an approved lab and get the test cost back in store credit →Free gift on orders $300+ · choose GLP-3 RT 5MG, GHK-Cu 100MG, NAD+ 500MG or MOTs-C 10MGUse code WELCOME10 for 10% off your orderFREE FEDEX 2-DAY shipping on orders over $250!Military · Veterans · First Responders: Verify & Save →
Disguised Alpha Β· CBL-514 Research

Is CBL-514 a Peptide or a Small Molecule?

Quick answer

Caliway describes CBL-514 as a small-molecule investigational drug candidate, not a peptide. A vial presentation or placement in a peptide supplier’s catalog does not change its chemical classification.

Disguised Alpha Β· November 11, 2026 Β· Sources reviewed November 11, 2026

Why the classification question comes up

People often encounter CBL-514 beside peptide products and assume that the same category applies. Catalog navigation is a shopping aid, however, not a chemical identification method. The developer’s research description identifies CBL-514 as a small molecule.[1]

A clear research note should preserve the compound’s name and distinguish the name from its class, formulation and intended experimental use. Those fields answer different questions. Mixing them can lead readers to attach unrelated peptide assumptions to a compound for which they have not been demonstrated.

Four labels that should stay separate

LabelWhat it tells you
CBL-514The development name being discussed
Small moleculeThe developer’s classification
Powder in a vialThe format described by a particular supplier
20 mgA labeled amount, requiring separate analytical verification

The DA listing currently describes a 20 mg powder vial. That description identifies the offered format; it does not supply a molecular structure, sequence or proof of equivalence to clinical material.[2]

How to write an accurate compound record

Use separate fields for the source of the classification, the supplier’s specification and the laboratory’s findings. Record unresolved identity details explicitly. Do not copy a molecular formula, sequence or registry identifier from an unverified marketplace listing simply to complete the form.

For example, a sensible entry might say β€œdeveloper classification: small molecule; supplied format: powder; lot-specific identity evidence: awaiting review.” This preserves what is known without turning an assumption into a measured result. It also makes the next documentation request clear.

Classification alone does not settle solubility, compatibility, stability or biological activity. Each requires evidence relevant to the material and conditions being evaluated.

Frequently asked questions

Does CBL-514 have a peptide sequence?

The developer describes it as a small molecule. A peptide sequence should not be assigned on the basis of a supplier category.

Does a small-molecule label confirm sample identity?

No. Classification is background information; identifying a supplied sample requires appropriate analytical evidence.

CBL-514 product and documentation

Review the current format and pack choices, then match the supplied lot to its documentation. No batch-specific identity, purity or content result is asserted in this article.

Sources

  1. Caliway: CBL-514 development program (developer source)
  2. Disguised Alpha: current CBL-514 20 mg listing

Publisher disclosure: Disguised Alpha sells the research material linked here. This supplier-published article provides research education and editorial interpretation; it is not an independent clinical review. Literature findings do not establish the identity or clinical performance of DA material.

Laboratory research only. Not for human or veterinary use. No affiliation with Caliway is claimed.

βœ“
Loading...
25% offGLPs15% off automaticallyUse code GLP or any code for 25% off0days00hrs00min00secShop the sale  →Shop